Affimed
AFMD
#10635
Rank
NZ$5.04 M
Marketcap
NZ$0.31
Share price
0.00%
Change (1 day)
-80.93%
Change (1 year)

Earnings for Affimed (AFMD)

Earnings in 2024 (TTM): -NZ$0.13 Billion

According to Affimed 's latest financial reports the company's current earnings are NZ$0.96 Million. In 2023 the company made an earning of -NZ$0.2 Billion a decrease over its 2022 earnings that were of -NZ$0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Affimed from 2013 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$0.13 Billion-36.53%
2023 -NZ$0.2 Billion26.6%
2022 -NZ$0.16 Billion36.51%
2021 -NZ$0.12 Billion38.05%
2020 -NZ$81.66 Million33.51%
2019 -NZ$61.16 Million54.17%
2018 -NZ$39.68 Million-32.35%
2017 -NZ$58.65 Million-3.51%
2016 -NZ$60.78 Million60.24%
2015 -NZ$37.93 Million3296.68%
2014 -NZ$1.12 Million-98.1%
2013 -NZ$58.79 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Repligen
RGEN
NZ$0.14 B-209.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.83 Million-97.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
NZ$35.01 M-127.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
-NZ$0.47 Billion 255.38%๐Ÿ‡บ๐Ÿ‡ธ USA